Experienced in Choriocarcinoma

Shirley S. Wong

50 Flemington Rd, 
Parkville, NSW, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Choriocarcinoma
50 Flemington Rd, 
Parkville, NSW, AU 
OverviewLocationsClinical Research

Overview

Shirley Wong practices in Parkville, Australia. Wong is rated as an Experienced expert by MediFind in the treatment of Choriocarcinoma. Their top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Choriocarcinoma, and Testicular Cancer.

Their clinical research consists of co-authoring 32 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Choriocarcinoma.

Locations

50 Flemington Rd, Parkville, NSW 3052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
Enrollment Status: Recruiting
Publish Date: June 15, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4): a Multicentre, Randomised, Controlled, Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: November 27, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 1/2 Dose Escalation and Expansion Study of Combination APL-501 or Nivolumab With APL-101 in Locally Advanced or Metastatic Hepatocellular and Renal Cell Carcinoma
A Phase 1/2 Dose Escalation and Expansion Study of Combination APL-501 or Nivolumab With APL-101 in Locally Advanced or Metastatic Hepatocellular and Renal Cell Carcinoma
Enrollment Status: Terminated
Publish Date: May 06, 2022
Intervention Type: Drug, Biological
Study Drugs: APL-501, APL-101, Nivolumab
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

32 Total Publications

Teams, tools, and time: a mixed methods study of workforce practices to identify mental health concerns in young people with complex communication needs.
Teams, tools, and time: a mixed methods study of workforce practices to identify mental health concerns in young people with complex communication needs.
Journal: Disability and rehabilitation
Published: August 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wong's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile